What Drives Poor Care for Child Diarrhea: A Standardized Patient Experiment
NCT04833790 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2451
Last updated 2024-04-30
Summary
Diarrhea is the second leading cause of death for children around the world, although nearly all of these deaths could be prevented with an inexpensive and simple treatment: oral rehydration salts (ORS). Many children with diarrhea do not receive ORS when they seek treatment and this study uses a field experiment to examine why this occurs. We will use anonymous standardized patients combined with a randomized ORS supply intervention to isolate the causal effect of several potential reasons for why children do not receive ORS when they seek care: 1) caretakers prefer ORS alternatives, 2) providers have a financial incentives to prescribe ORS alternatives, and 3) ORS is often out of stock.
Conditions
- Child Diarrhea
Interventions
- BEHAVIORAL
-
Free distribution of ORS
Provides will receive 3 months supply of ORS at the beginning of the study to dispense to their patients. They will be asked to dispense the ORS at the market rate and not to give it away to other providers.
- BEHAVIORAL
-
Standardized patient with ORS preference
Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who requests ORS to treat their child's diarrhea.
- BEHAVIORAL
-
Standardized patient with Antibiotic preference
Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who requests Antibiotics to treat their child's diarrhea.
- BEHAVIORAL
-
Standardized patient with no preference
Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who does not request anything specific to treat their child's diarrhea.
- BEHAVIORAL
-
Standardized patient with no preference + no financial incentive
Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who does not request anything specific to treat their child's diarrhea. In addition they will inform the provider that they are not going to purchase anything from the provider because they have an uncle with a drug shop where they can get a discount.
Sponsors & Collaborators
-
RAND
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-05
- Primary Completion
- 2022-12-31
- Completion
- 2025-06-01
Countries
- India
Study Locations
More Related Trials
-
Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea
NCT05814042 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of iOWH032 in Dehydrating Cholera
NCT02111304 ·Status: WITHDRAWN ·Phase: PHASE2
-
Working With Community Health Workers to Increase ORS Use in Uganda
NCT02870491 ·Status: COMPLETED ·Phase: NA
-
VS002A in the Treatment of Acute Watery Diarrhea in Infants and Young Children
NCT06179589 ·Status: COMPLETED ·Phase: NA
-
Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting
NCT00278746 ·Status: COMPLETED ·Phase: NA
-
Oral Rehydration Solution With Zinc and Prebiotics in Acute Diarrhea
NCT01025583 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Isoleucine Added ORS in Children With Diarrhoea
NCT01034228 ·Status: COMPLETED ·Phase: PHASE2
-
Zinc-ORS in Severe and Complicated Acute Diarrhea
NCT00370968 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute Gastroenteritis
NCT01467570 ·Status: COMPLETED ·Phase: PHASE4
-
Zinc Dosing Trial - Does Dose Reduction Reduce Side Effects But Retain Efficacy in Diarrhoea Management
NCT03078842 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea
NCT03473561 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Adding Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting
NCT00278681 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Zinc for the Treatment of Acute Diarrhea in US Children
NCT01198587 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute
NCT02601742 ·Status: UNKNOWN ·Phase: PHASE3
-
Oral Administration of Tannins and Flavonoids in Children With Acute Diarrhea
NCT03356327 ·Status: COMPLETED ·Phase: PHASE4
-
Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute Diarrhea
NCT03463512 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Smecta in the Treatment of Acute Diarrhoea in Children
NCT00352716 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Racecadotril in Acute Watery Diarrhea in Children
NCT01577043 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotics for Children With Severe Diarrhoea
NCT03130114 ·Status: COMPLETED ·Phase: PHASE3
-
Community Based Intervention and Evaluation of the Impact of Social Marketing of a Diarrhea Management Pack
NCT00942812 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Prompting the Supply of Zinc/LO-ORS Co-packs in the Private Sector Plus BCI on Childhood Diarrhea Treatment
NCT04335877 ·Status: COMPLETED ·Phase: NA
-
Safety, Efficacy and Cost-effectiveness of Racecadotril in Children With Acute Diarrhea in Mexico
NCT01153854 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Low Osmolar ORS and ReSoMal for Treating Acute Watery Diarrhea in Severely Malnourished Children Aged 6 Months to 5 Years
NCT07026682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Acceptability and Impact of Diarrheal Etiology Prediction (DEP) Algorithm
NCT04602676 ·Status: COMPLETED ·Phase: NA
-
Gelatin Tannate as Treatment for Acute Childhood Gastroenteritis
NCT02644200 ·Status: COMPLETED ·Phase: PHASE3